This is only a limited clinical observation and not sufficient to infer causality, but it was interesting to later see similar signals emerging in early observational studies
The Noom, a well-established digital healthcare company focused on chronic disease prevention and encouraging people to live a quality and longer life, launched the Noom microdose GLP-1program, a commendable initiative providing long-term health and weight-loss benefits with fewer side effects via personalized microdoses of GLP-1 medication, in clinical accuracy cases
others tolerate morning injections better because daytime activity masks early nausea
2019 (10) CD004052
Specifically, mice and rats exhibit behavioral features that are relevant in ASD, including changes in level of activity, stereotypic, repetitive behaviors, social interactions [12]
Not an FDA-approved finished drug